Denene Lofland received a Ph.D. in Pathology, with an emphasis in microbiology, from the Medical College of Virginia. As a former biotech company director, Denene managed successful clinical projects that resulted in FDA approval for two new antimicrobial drugs for the treatment of pneumonia and cystic fibrosis. She also supervised several projects, including government-sponsored research which required her to maintain a secret security clearance. Denene is a renowned scientist known for her expertise in DNA, bioterrorism, and new drug discovery, such as supervision of research for pre-clinical anti-infective drug candidates and drug development through Phase III clinical trials, including FDA and/or EMEA regulatory filings of four compounds. She has published several articles in a variety of scientific journals and contributed to the thirteenth edition of Bailey and Scott’s Diagnostic Microbiology. Denene currently serves as a professor at Touro University California/College of Osteopathic Medicine.
*Dr. Lofland is sponsored by Patti Phillips.